US Stock MarketDetailed Quotes
AMIX Autonomix Medical
- 10.920
- -3.390-23.69%
Close Nov 1 16:00 ET
- 10.570
- -0.350-3.21%
Post 20:02 ET
12.58MMarket Cap-608P/E (TTM)
13.250High10.300Low393.66KVolume12.790Open14.310Pre Close4.59MTurnover60.66%Turnover RatioLossP/E (Static)1.15MShares152.00052wk High2.37P/B7.09MFloat Cap7.51052wk Low--Dividend TTM648.91KShs Float152.000Historical High--Div YieldTTM20.62%Amplitude7.510Historical Low11.653Avg Price1Lot Size
Autonomix Medical Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||
| Cash flow from continuing operating activities | -180.18%-1.85M | -258.58%-6.65M | -268.87%-2.29M | -661K | -1.85M | -620K |
| Net income from continuing operations | -212.02%-2.7M | -675.18%-15.43M | -723.14%-5.41M | ---865K | ---1.99M | ---657K |
| Operating gains losses | ---- | --8M | --3.03M | ---- | ---- | ---- |
| Depreciation and amortization | --43K | --81K | --46K | --0 | --0 | --0 |
| Change In working capital | 117.65%444K | -41.91%79K | -656.76%-206K | --204K | --136K | --37K |
| -Change in payables and accrued expense | -106.11%-14K | 338.58%557K | -627.03%-195K | --229K | --127K | --37K |
| -Change in other current assets | 1,932.00%458K | -5,411.11%-478K | ---11K | ---25K | --9K | --0 |
| Cash from discontinued investing activities | ||||||
| Operating cash flow | -180.18%-1.85M | -258.58%-6.65M | -268.87%-2.29M | ---661K | ---1.85M | ---620K |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -5K | -19K | -3K | 0 | 0 | 0 |
| Net PPE purchase and sale | ---5K | ---19K | ---3K | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | ---5K | ---19K | ---3K | --0 | --0 | --0 |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 0 | 2,034.81%14.41M | 1,334.07%9.68M | 2.74M | 675K | 675K |
| Net issuance payments of debt | ---- | --2M | --0 | ---- | --0 | --0 |
| Net common stock issuance | --0 | 1,930.52%13.71M | 1,509.78%10.87M | --2.84M | --675K | --675K |
| Net other financing activities | ---- | ---1.3M | ---1.19M | ---105K | ---- | ---- |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | --0 | 2,034.81%14.41M | 1,334.07%9.68M | --2.74M | --675K | --675K |
| Net cash flow | ||||||
| Beginning cash position | 895.14%8.61M | -57.68%865K | 50.37%1.22M | --865K | --2.04M | --810K |
| Current changes in cash | -189.54%-1.86M | 756.74%7.74M | 13,336.36%7.39M | --2.07M | ---1.18M | --55K |
| End cash Position | 129.70%6.75M | 895.14%8.61M | 895.14%8.61M | --2.94M | --865K | --865K |
| Free cash flow | -180.94%-1.86M | -259.60%-6.67M | -269.35%-2.29M | ---661K | ---1.85M | ---620K |
| Currency Unit | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data